Peter Fernandes

Insider Reports History

Entity
Individual
Location
Perryville III Corporate Park, 53 Frontage Road, Suite 301, Hampton, NJ
Signature
/s/ Peter Fernandes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Fernandes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. Chief Executive Officer, Principal Financial and Accounting Officer Stock Options (Right to Buy) 100K $310K $3.10 Jun 7, 2023 Direct

Insider Reports Filed by Peter Fernandes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Chief Executive Officer, Principal Financial and Accounting Officer
BLPH Bellerophon Therapeutics, Inc. Feb 10, 2023 1 $152K 4 Feb 14, 2023 CHIEF EXECUTIVE OFFICER
BLPH Bellerophon Therapeutics, Inc. Dec 9, 2022 3 -$9.29K 4 Dec 13, 2022 PRINCIPAL EXECUTIVE OFFICER
BLPH Bellerophon Therapeutics, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 CHIEF REGULATORY & SAFETY OFFR